CompletedPhase 4ketamine

Ketamine Tolerance in Children After Repeated Administrations During Radiotherapy Sessions

Sponsored by Baskent University

NCT ID
NCT02512055
Target Enrollment
33 participants
Start Date
2012-05
Est. Completion
2014-05

About This Study

Ketamine provides a safety zone for sedated but spontaneously ventilated children especially in remote conditions such as radiotherapy units where sedation is an essential practice for children to keep calm and motionless In this study, investigators planned to analyse ketamine doses needed and the recovery times in pediatric oncology patients undergoing repeated radiotherapy sessions.

Conditions Studied

Conscious Sedation Failure During Procedure

Interventions

  • Ketamine

Eligibility

Age:1 Year - 14 Years
Healthy Volunteers:No
View full eligibility criteria
Inclusion Criteria:

* pediatric patients undergoing radiotherapy due to oncologic disorders

Exclusion Criteria:

* Patients younger than 1 year and older than 14 year,
* patients with cardiac, renal or liver function abnormalities, who were already under sedative drug treatment or allergic to the drugs to be used or the patients for whom the study drugs

This trial is not recruiting

This study has completed enrollment. Check back for results or find similar trials.

Find recruiting trials
Data Source
ClinicalTrials.gov

Last updated from source